Navigation Links
Abraxis BioScience Presents Data from Pre-Clinical Study That,Provide Evidence for Chemotherapy-Induced Angiogenesis and,Rationale for Combining nab-Paclitaxel (Abraxane) with,Anti-Angiogenic Agents to Increase Tumor Response

s Exchange Act of 1934, as amended. Forward-looking statements in this press release include statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the timing and scope of clinical studies and trials for nab-rapamycin mTOR inhibitor (ABI 009), and nab-17AAG HSP90 inhibitor (ABI 010). Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those in the forward-looking statements. These factors include, without limitation, the fact that results from pre-clinical studies may not be predictive of results to be obtained in other pre-clinical studies or future clinical trials, delays in commencement and completion of clinical trials, including slower than anticipated patient enrollment and adverse events occurring during the clinical trials, the impact of pharmaceutical industry regulation, the impact of competitive products and pricing, the availability and pricing of ingredients used in the manufacture of pharmaceutical products, the ability to successfully manufacture products in a time-sensitive and cost effective manner, the acceptance and demand of new pharmaceutical products, the impact of patents and other proprietary rights held by competitors and other third parties. Additional relevant information concerning risks can be found in Abraxis BioScience's Form 10-K for the year ended December 31, 2006 and other documents it has filed with the Securities and Exchange Commission.

The information contained in this press release is as of the date of this release. Abraxis assumes no obligations to update any forward-looking statements contained in this press release as the result of new information or future events or developments.

Avastin(R) (bevacizumab) is a registered trademark of Genentech Inc.

Taxol(R) (paclitaxel) is a registered trademark of Bristol-Myers Squibb Co
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Abraxis BioScience Presents Results from Pre-Clinical Study That Demonstrates nab-Rapamycins Robust Antitumor Properties and Ability to Target Intracellular Sites Such as the mTOR Pathway
2. Abraxis BioScience Presents Pre-Clinical Findings That Support Role of SPARC Expression in Cancer and the Role of the Nanoparticle Albumin Bound (nab) Technology Platform in Targeting the Pathway
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
4. YM BioSciences Announces Preclinical Data Confirming Nimotuzumab Binds to the EGF Receptor and Potentiates Radiotherapy
5. Sangamo BioSciences Announces Presentation of Phase 1 ZFP Therapeutic Data at American Diabetes Association Meeting
6. IR BioSciences Announces Promising Data from Study of Its Compound Homspera
7. Sangamo BioSciences Announces Presentation of ZFP Therapeutic Data From Nerve Regeneration Program at American Society for Neural Therapy and Repair Meeting
8. YM BioSciences Reports AeroLEF Randomized Phase IIb Trial Meets Primary Endpoint in Patients with Post-Surgical Pain
9. ImmuneRegen BioSciences Announces Promising Data on Homspera Suggesting Potential as a Co-Therapeutic Agent
10. Study in Cell by Magen BioSciences Co-Founder David E. Fisher Identifies New Roles in Skin Cancer Prevention for Key Tumor Suppressor Protein
11. IR BioSciences Announces Data Demonstrating Radilex Stimulation of Stem Cells Results in Hematopoietic Recovery Following Lethal Irradiation
Post Your Comments:
(Date:5/21/2015)... Increasing requirements, including rising surface pressures ... indispensable in the chemical and pharmaceutical industries. However, ... major challenges to their performance. Freudenberg-NOK Sealing Technologies ... materials whose scope covers the given requirements in ... FG-360, based on DIN 28091-3, is completely constructed ...
(Date:5/21/2015)... 2015 Thirteen winners of the Neuro ... bring promising medical inventions to market, were announced ... collaboration with the National Institutes of Health (NIH) ... winning teams were selected based on their business ... move forward to phase three of the challenge ...
(Date:5/21/2015)... 21, 2015 Omnicell, Inc. , (NASDAQ: ... its Unity enterprise platform, the premier medication and supply ... patient care venues throughout hospitals and health care systems. ... the Epic electronic health record (EHR) and the Omnicell ... needs of health care providers. Through a partnership with ...
Breaking Medicine Technology:Flat gaskets for especially demanding applications in the processing industry 2Neuro Startup Challenge selects 13 winning teams to launch startups for unlicensed NIH technologies to improve brain health 2Neuro Startup Challenge selects 13 winning teams to launch startups for unlicensed NIH technologies to improve brain health 3Neuro Startup Challenge selects 13 winning teams to launch startups for unlicensed NIH technologies to improve brain health 4Omnicell Enhances Unity Enterprise Platform to Allow Increased Interoperability for Hospitals and Health Systems 2Omnicell Enhances Unity Enterprise Platform to Allow Increased Interoperability for Hospitals and Health Systems 3Omnicell Enhances Unity Enterprise Platform to Allow Increased Interoperability for Hospitals and Health Systems 4
... March 7, 2011 General Nutrition Company (GNC) today ... manufacturer Sakar International for a line of more than ... initial merchandise offerings will range from heart rate and ... electronic pill boxes. The products will ...
... Inc., a leading provider of specialty medical products to ... B. Petras, Jr. as Chief Executive Officer, effective March ... from GE Lighting, the Cleveland-based $3 billion unit of ... he served as President and Chief Executive Officer.  Michael ...
Cached Medicine Technology:GNC Teams With Sakar International for Branded Health and Wellness Product Line 2GNC Teams With Sakar International for Branded Health and Wellness Product Line 3Michael Petras, Former CEO of GE Lighting, Named CEO of Cleveland-Based Specialty Medical Supplies Leader 2Michael Petras, Former CEO of GE Lighting, Named CEO of Cleveland-Based Specialty Medical Supplies Leader 3
(Date:5/21/2015)... The Johns Hopkins Alliance for Science and Technology ... Board has selected a research project at the Veterans ... two $50,000 Abell Foundation Award for Excellence in Innovation ... Developed by the VA Maryland Exercise and Robotics ... Maryland School of Medicine and Massachusetts Institute of Technology ...
(Date:5/21/2015)... May 21, 2015 How do you stop ... question for parents and school administrators, but a Miami Lice ... based in southern Florida, is devising new ways to ... professionals will tell you, the first step is education and ... classrooms, head lice and how they spread are still widely ...
(Date:5/21/2015)... May 21, 2015 The ThedaCare Center for ... new full-time role as president. Barnas is based in Appleton ... focus is to coach, lead and support Center teams that ... , Transforming the patient experience , Making ... across North America. , The Center is excited ...
(Date:5/21/2015)... 21, 2015 PharmApprove – ... the pharmaceutical and biotechnology industries – will be presenting ... BIO International Convention in Philadelphia, PA. PharmApprove’s session, titled ... Payer,” will take place on June 16th at ... PharmApprove President and CSO, will moderate the group, which ...
(Date:5/21/2015)... An existing anti-stroke drug is an ... to suppress mucus overproduction, improve bacterial clearance and ... State University and the University of Rochester. , ... of Immunology, could result in a novel, non-antibiotic ... through topical drug delivery. Vinpocetine, the drug involved ...
Breaking Medicine News(10 mins):Health News:VA Maryland Health Care System Researchers Selected for Abell Foundation Innovation Award 2Health News:VA Maryland Health Care System Researchers Selected for Abell Foundation Innovation Award 3Health News:Local Lice Removal Company Partners with Schools to Combat Head Lice in the Classroom as Increase in Number of Cases Reported in May. 2Health News:Kim Barnas joins ThedaCare Center for Healthcare Value 2Health News:PharmApprove Panel at BIO Addresses Success in Drug Development Beyond Regulatory Approval 2Health News:PharmApprove Panel at BIO Addresses Success in Drug Development Beyond Regulatory Approval 3Health News:Anti-Stroke Drug Effective Treatment for Middle-Ear Infections, Researchers Say 2Health News:Anti-Stroke Drug Effective Treatment for Middle-Ear Infections, Researchers Say 3
... (Linkwell) (OTC Bulletin Board: LWLL), a leading developer,manufacturer ... today that it will file a Form 12b-25 ... 15-calendar day extension to file its 2007,Annual Report ... allow additional,time to complete the Company,s 2007 financial ...
... to 13 minutes, contrary to popular fantasy about the ... survey of U.S. and Canadian sex therapists., Penn State ... survey of 50 full members of the Society for ... workers, marriage/family therapists and nurses who have collectively seen ...
... CalbaTech,Inc. (OTC Bulletin Board: CLBE), the emerging life ... collection and banking of,adult stem cells for possible ... by $999,926 in 2007., CalbaTech announced revenues ... million in 2006. Gross profit in 2007 totaled ...
... Gan has established that patients with a high blood pressure ... capable of pumping blood against this pressure. Further, the right ... Gan is the first Mosaic laureate to gain his doctorate. ... out into the cause of high blood pressure in the ...
... University of Florida chemists are the first to use a ... -- without any previous knowledge of what these microscopic signatures ... the online edition of the Journal of Proteome Research, the ... treatment of some types of cancer as well as other ...
... Provides Interventional Cardiologists with Enhanced ... Faster, More Precise Procedures, CHICAGO, March 31 According ... 1 killer,with an average of one death every 37 seconds. ... contributed to the surge of,Americans with cardiac issues. To address ...
Cached Medicine News:Health News:Linkwell Corp to File to Extend Filing Date for 2007 Form 10-K 2Health News:Good sexual intercourse lasts minutes, not hours, therapists say 2Health News:CalbaTech Announces $999,926 Reduction in Debt; First Adult Stem Cell Harvesting Scheduled 2Health News:CalbaTech Announces $999,926 Reduction in Debt; First Adult Stem Cell Harvesting Scheduled 3Health News:Scientists: New technique identifies molecular 'biomarkers' for disease 2Health News:Scientists: New technique identifies molecular 'biomarkers' for disease 3Health News:See More, Do More: Siemens Highlights New Generation of Interventional Imaging Systems for Cardiology at ACC 2Health News:See More, Do More: Siemens Highlights New Generation of Interventional Imaging Systems for Cardiology at ACC 3Health News:See More, Do More: Siemens Highlights New Generation of Interventional Imaging Systems for Cardiology at ACC 4
... suspension in methanol for faster, more ... histology smears. Our special manufacturing process ... cellular elements producing unequaled definition of ... unexcelled brilliance in the resulting smear. ...
Wright-Giemsa Stain Solutions...
... Statim Stain is ideal for stat, routine ... blood smears and bone marrow. Our unique ... which yield excellent color intensity and morphological ... involved in the Wright's staining procedure and ...
This stain is the McNeal formula and can be substituted for Wright Stain solution....
Medicine Products: